Atypical Teratoid/Rhabdoid Tumor — Trials

Atypical Teratoid/Rhabdoid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Seattle Children's Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00653068	Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System	completed	Phase 3	70	Children's Oncology GroupNETWORK	3	Apr 23, 2024	clinicaltrials

Data updated 23 days agoSource updated Apr 23, 2024source: clinicaltrials